Association of corticosteroid (CS) exposure with treatment failure in patients (pts) with advanced melanoma treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Le, H. M. L. [1 ]
Pozas Perez, J. [2 ]
San Roman Gil, M. V. [2 ]
Serrano Domingo, J. J. [2 ]
Larkin, J. [1 ]
机构：
[1] NHS Fdn Trust, Med Dept, Royal Marsden Hosp, London, England
[2] Ramon y Cajal Univ Hosp, Med Oncol Dept, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1158P
引用
收藏
页码：S691 / S691
页数：1
相关论文
共 50 条
  • [21] Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors
    Sonke, Eric
    Angeles, Arkhjamil
    Nguyen, Thao Phuong
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Association of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors
    Howell, Ashley, V
    Gebregziabher, Mulugeta
    Thiers, Bruce H.
    Graboyes, Evan M.
    Paulos, Chrystal M.
    Wrangle, John M.
    Hunt, Kelly J.
    Wallace, Kristin
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) : 1003 - 1010
  • [23] Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors
    Mantia, Charlene M. M.
    Werner, Lillian
    Stwalley, Brian
    Ritchings, Corey
    Tarhini, Ahmad A. A.
    Atkins, Michael B. B.
    McDermott, David F. F.
    Regan, Meredith M. M.
    MELANOMA RESEARCH, 2022, 32 (01) : 35 - 44
  • [24] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
    Bolte, Laura A.
    Lee, Karla A.
    Bjork, Johannes R.
    Leeming, Emily R.
    Campmans-Kuijpers, Marjo J. E.
    de Haan, Jacco J.
    Vila, Arnau Vich
    Maltez-Thomas, Andrew
    Segata, Nicola
    Board, Ruth
    Harries, Mark
    Lorigan, Paul
    de Vries, Elisabeth G. E.
    Nathan, Paul
    Fehrmann, Rudolf
    Bataille, Veronique
    Spector, Tim D.
    Hospers, Geke A. P.
    Weersma, Rinse K.
    JAMA ONCOLOGY, 2023, 9 (05) : 705 - 709
  • [26] Sensitivity of treatment-free survival (TFS), a novel outcome, to subgroup analyses of patients (pts) with advanced melanoma (MEL) treated with immune checkpoint inhibitors (ICI).
    Mantia, Charlene
    Werner, Lillian
    Rao, Sumati
    Ritchings, Corey
    Tarhini, Ahmad A.
    Atkins, Michael B.
    McDermott, David F.
    Regan, Meredith M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [28] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05): : 640 - 647
  • [29] Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
    Zhi, X.
    Zhang, Z.
    Li, W.
    Yan, X.
    Zhang, F.
    Han, X.
    Yuan, F.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Ge, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S582
  • [30] Outcome and impact of immune related adverse events in patients with advanced melanoma treated with checkpoint inhibitors
    Angeles, A.
    Wind, K.
    Tong, C.
    Lee, D. G.
    Bernstein, V.
    Metcalf, C.
    Bahl, G.
    Nguyen, T. P.
    Savage, K. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S878 - S878
12345